Abstract
Neuroinflammation and oxidative stress are elements present in the vast majority of pathological conditions. Therefore, substances capable of modulating anti-inflammatory and oxidative pathways have been considered as a promising strategy to attenuate these processes and, consequently, reduce symptoms and delay the progression of neurodegenerative diseases and other psychopathologies. In …